| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2025 | Apr 1, 2025 | Avalo Therapeutics, Inc. | CEO | Sell | 22.5 | -17,787 | -27.40% | ✗ | $150.5K |
| Jun 9, 2023 | Jun 13, 2023 | Avalo Therapeutics, Inc. | CEO | Buy | 91.3 | +4,000 | 43.38% | ✗ | $13.7K |
| Dec 9, 2022 | Dec 12, 2022 | Avalo Therapeutics, Inc. | CEO | Buy | 90.0 | +2,083 | 29.19% | ✗ | $9.2K |
| Dec 10, 2021 | Dec 14, 2021 | Avalo Therapeutics, Inc. | Chief Scientific Officer | Buy | 85.0 | +4,267 | 5.24% | ✗ | $6.7K |
| Jun 10, 2021 | Jun 14, 2021 | Avalo Therapeutics, Inc. | Chief Scientific Officer | Buy | 82.5 | +3,692 | 4.75% | ✗ | $8.4K |
| Dec 10, 2020 | Dec 14, 2020 | Avalo Therapeutics, Inc. | Chief Scientific Officer | Buy | 82.5 | +3,599 | 4.86% | ✗ | $8.2K |
| Jun 10, 2020 | Jun 11, 2020 | Avalo Therapeutics, Inc. | Chief Scientific Officer | Buy | 77.5 | +1,799 | 2.49% | ✗ | $4.1K |